antiaging

antiagingVenture Capital Accelerating and Shifting to AI and Other Breakthrough Technologies

Global Venture capital for 2018 and 2019 has been about $200-250 billion. US Venture capital reached $130 billion. This surpassed the level in 2000 when it was $100 billion. There is $9-10 billion per year funding Artificial Intelligence and $5.8 …

antiagingAntiaging Treatments that are Closest to FDA Approval

There are a few dozen antiaging rejuvenation treatments that are progressing through pre-clinical and clinical trials. Lifespan.io is tracking the antiaging rejuvenation treatments on a rejuvenation roadmap. Two treatments are in phase 3 clinical trial. Samumed is developing drugs for …

antiagingTechnology Progresses While Problems Remain Unsolved

When futurists predict that technology X will be developed, there is a common reply from people who do not know the history of technology. The replies are variations of “Technology X will be developed after we solve Y”. Y can …

antiagingUnderdog Pharma Could Reverse Cardiovascular Disease Which is the Leading Medical Problem

Underdog Pharma is developing disease-modifying treatments for atherosclerosis and other age-related diseases. They want to prevent or reverse atherosclerosis by removing a harmful lipid known as 7-ketocholesterol (7KC) from the arterial walls. Underdog has a molecule that can extract the …

antiagingOne Plus One Cellular Modification Gives Five Times the Anti-aging Effect in Worms

Scientists at the MDI Biological Laboratory, in collaboration with scientists from the Buck Institute for Research on Aging in Novato, Calif., and Nanjing University in China, have identified synergistic cellular pathways for longevity that amplify lifespan fivefold in C. elegans, …

antiagingCombination Gene Therapy Progressing Against Aging

George Church indicates Rejuvenate Bio is working toward combination gene therapy against 300+ human genes that effect aging. There is also progress in super-resolution imaging of chromosomes and hyper-detailed tissue analysis. They will be able to analyze the DNA in …

alzheimer'sLeading Edge Biotechnology to Enhance Organs for Cryonics, Space and Transplants

George Church describes the leading edge of biotechnology. He described antiaging and gene reading and writing capabilities. George Church Described Other Leading Edge Biotechnology They are closer to making organoids in days and they are vascularized. Having veins will enable …

alzheimer'sAlzheimer’s Drugs Reverse Broader Aging

In mouse models of Alzheimer’s disease, the drug candidates (CMS121 and J147) improve memory and slow the degeneration of brain cells. Researchers have shown how these compounds can also slow aging in healthy older mice, blocking the damage to brain …

antiagingDemographics and the Transition to Over 200 Year Lifespans

The UN population projections assume that world lifespans increase from 72.6 today to 77 in 2050 and then about 82 in 2100. There are already populations that have life expectancy over 92 years. Asian American women in New Jersey life …

antiagingTHIO is a Telomerase-Mediated Approach to Fighting Cancer

Telomerase is present in 90% of human cancer cells and contributes significantly to proliferative abilities and immortality of cancer cells. MAIA Biotechnology is developing a Telomerase-Mediated Approach to Fighting Cancer. Telomerase is either absent or shows low activity in normal …